Isomorphic Labs Raises $5B as AI Drug Design Faces Trial Test
Isomorphic Labs raised $5 billion to expand IsoDDE and clinical infrastructure. The Series C follows two earlier rounds, while human trial results remain the decisive test.
Topic
Topic
Isomorphic Labs raised $5 billion to expand IsoDDE and clinical infrastructure. The Series C follows two earlier rounds, while human trial results remain the decisive test.